Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Author Correction: The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD.

Soderborg TK, Clark SE, Mulligan CE, Janssen RC, Babcock L, Ir D, Young B, Krebs NF, Lemas DJ, Johnson LK, Weir T, Lenz LL, Frank DN, Hernandez TL, Kuhn KA, D'Alessandro A, Barbour LA, El Kasmi KC, Friedman JE.

Nat Commun. 2019 Jul 1;10(1):2965. doi: 10.1038/s41467-019-10943-1.

2.

The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD.

Soderborg TK, Clark SE, Mulligan CE, Janssen RC, Babcock L, Ir D, Young B, Krebs N, Lemas DJ, Johnson LK, Weir T, Lenz LL, Frank DN, Hernandez TL, Kuhn KA, D'Alessandro A, Barbour LA, El Kasmi KC, Friedman JE.

Nat Commun. 2018 Oct 26;9(1):4462. doi: 10.1038/s41467-018-06929-0. Erratum in: Nat Commun. 2019 Jul 1;10(1):2965.

3.

Immunotolerant p50/NFκB Signaling and Attenuated Hepatic IFNβ Expression Increases Neonatal Sensitivity to Endotoxemia.

McKenna S, Burey T, Sandoval J, Nguyen L, Castro O, Gudipati S, Gonzalez J, El Kasmi KC, Wright CJ.

Front Immunol. 2018 Sep 26;9:2210. doi: 10.3389/fimmu.2018.02210. eCollection 2018.

4.

Macrophage-derived IL-1β/NF-κB signaling mediates parenteral nutrition-associated cholestasis.

El Kasmi KC, Vue PM, Anderson AL, Devereaux MW, Ghosh S, Balasubramaniyan N, Fillon SA, Dahrenmoeller C, Allawzi A, Woods C, McKenna S, Wright CJ, Johnson L, D'Alessandro A, Reisz JA, Nozik-Grayck E, Suchy FJ, Sokol RJ.

Nat Commun. 2018 Apr 11;9(1):1393. doi: 10.1038/s41467-018-03764-1.

5.

Pyrroloquinoline quinone prevents developmental programming of microbial dysbiosis and macrophage polarization to attenuate liver fibrosis in offspring of obese mice.

Friedman JE, Dobrinskikh E, Alfonso-Garcia A, Fast A, Janssen RC, Soderborg TK, Anderson AL, Reisz JA, D'Alessandro A, Frank DN, Robertson CE, de la Houssaye BA, Johnson LK, Orlicky DJ, Wang XX, Levi M, Potma EO, El Kasmi KC, Jonscher KR.

Hepatol Commun. 2018 Jan 22;2(3):313-328. doi: 10.1002/hep4.1139. eCollection 2018 Mar.

6.

Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis.

Zhang H, Wang D, Li M, Plecitá-Hlavatá L, D'Alessandro A, Tauber J, Riddle S, Kumar S, Flockton A, McKeon BA, Frid MG, Reisz JA, Caruso P, El Kasmi KC, Ježek P, Morrell NW, Hu CJ, Stenmark KR.

Circulation. 2017 Dec 19;136(25):2468-2485. doi: 10.1161/CIRCULATIONAHA.117.028069. Epub 2017 Sep 26.

7.

Cancer-promoting mechanisms of tumor-associated neutrophils.

Hurt B, Schulick R, Edil B, El Kasmi KC, Barnett C Jr.

Am J Surg. 2017 Nov;214(5):938-944. doi: 10.1016/j.amjsurg.2017.08.003. Epub 2017 Aug 10. Review.

PMID:
28830617
8.

Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming.

D'Alessandro A, El Kasmi KC, Plecitá-Hlavatá L, Ježek P, Li M, Zhang H, Gupte SA, Stenmark KR.

Antioxid Redox Signal. 2018 Jan 20;28(3):230-250. doi: 10.1089/ars.2017.7217. Epub 2017 Aug 14. Review.

9.

A Time- and Compartment-Specific Activation of Lung Macrophages in Hypoxic Pulmonary Hypertension.

Pugliese SC, Kumar S, Janssen WJ, Graham BB, Frid MG, Riddle SR, El Kasmi KC, Stenmark KR.

J Immunol. 2017 Jun 15;198(12):4802-4812. doi: 10.4049/jimmunol.1601692. Epub 2017 May 12.

10.

Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.

Li M, Riddle S, Zhang H, D'Alessandro A, Flockton A, Serkova NJ, Hansen KC, Moldvan R, McKeon BA, Frid M, Kumar S, Li H, Liu H, Caánovas A, Medrano JF, Thomas MG, Iloska D, Plecitá-Hlavatá L, Ježek P, Pullamsetti S, Fini MA, El Kasmi KC, Zhang Q, Stenmark KR.

Circulation. 2016 Oct 11;134(15):1105-1121. Epub 2016 Aug 25. Erratum in: Circulation. 2019 Jan 8;139(2):e1.

11.

Constitutive Reprogramming of Fibroblast Mitochondrial Metabolism in Pulmonary Hypertension.

Plecitá-Hlavatá L, Tauber J, Li M, Zhang H, Flockton AR, Pullamsetti SS, Chelladurai P, D'Alessandro A, El Kasmi KC, Ježek P, Stenmark KR.

Am J Respir Cell Mol Biol. 2016 Jul;55(1):47-57. doi: 10.1165/rcmb.2015-0142OC.

12.

Contribution of metabolic reprogramming to macrophage plasticity and function.

El Kasmi KC, Stenmark KR.

Semin Immunol. 2015 Aug;27(4):267-75. doi: 10.1016/j.smim.2015.09.001. Epub 2015 Oct 9. Review.

13.

Endotoxemia Induces IκBβ/NF-κB-Dependent Endothelin-1 Expression in Hepatic Macrophages.

McKenna S, Gossling M, Bugarini A, Hill E, Anderson AL, Rancourt RC, Balasubramaniyan N, El Kasmi KC, Wright CJ.

J Immunol. 2015 Oct 15;195(8):3866-79. doi: 10.4049/jimmunol.1501017. Epub 2015 Sep 4.

14.

Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension.

Stenmark KR, Tuder RM, El Kasmi KC.

J Appl Physiol (1985). 2015 Nov 15;119(10):1164-72. doi: 10.1152/japplphysiol.00283.2015. Epub 2015 Apr 30. Review.

15.

The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.

Pugliese SC, Poth JM, Fini MA, Olschewski A, El Kasmi KC, Stenmark KR.

Am J Physiol Lung Cell Mol Physiol. 2015 Feb 1;308(3):L229-52. doi: 10.1152/ajplung.00238.2014. Epub 2014 Nov 21. Review.

16.

Specific microbiome changes in a mouse model of parenteral nutrition associated liver injury and intestinal inflammation.

Harris JK, El Kasmi KC, Anderson AL, Devereaux MW, Fillon SA, Robertson CE, Wagner BD, Stevens MJ, Pace NR, Sokol RJ.

PLoS One. 2014 Oct 20;9(10):e110396. doi: 10.1371/journal.pone.0110396. eCollection 2014.

17.

Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension.

El Kasmi KC, Pugliese SC, Riddle SR, Poth JM, Anderson AL, Frid MG, Li M, Pullamsetti SS, Savai R, Nagel MA, Fini MA, Graham BB, Tuder RM, Friedman JE, Eltzschig HK, Sokol RJ, Stenmark KR.

J Immunol. 2014 Jul 15;193(2):597-609. doi: 10.4049/jimmunol.1303048. Epub 2014 Jun 13.

18.

Early life exposure to maternal insulin resistance has persistent effects on hepatic NAFLD in juvenile nonhuman primates.

Thorn SR, Baquero KC, Newsom SA, El Kasmi KC, Bergman BC, Shulman GI, Grove KL, Friedman JE.

Diabetes. 2014 Aug;63(8):2702-13. doi: 10.2337/db14-0276. Epub 2014 Apr 4.

19.

Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease.

El Kasmi KC, Anderson AL, Devereaux MW, Vue PM, Zhang W, Setchell KD, Karpen SJ, Sokol RJ.

Sci Transl Med. 2013 Oct 9;5(206):206ra137. doi: 10.1126/scitranslmed.3006898.

20.

Role of arginase 1 from myeloid cells in th2-dominated lung inflammation.

Barron L, Smith AM, El Kasmi KC, Qualls JE, Huang X, Cheever A, Borthwick LA, Wilson MS, Murray PJ, Wynn TA.

PLoS One. 2013 Apr 24;8(4):e61961. doi: 10.1371/journal.pone.0061961. Print 2013.

21.

Superoxide dismutase mimetic, MnTE-2-PyP, attenuates chronic hypoxia-induced pulmonary hypertension, pulmonary vascular remodeling, and activation of the NALP3 inflammasome.

Villegas LR, Kluck D, Field C, Oberley-Deegan RE, Woods C, Yeager ME, El Kasmi KC, Savani RC, Bowler RP, Nozik-Grayck E.

Antioxid Redox Signal. 2013 May 10;18(14):1753-64. doi: 10.1089/ars.2012.4799. Epub 2013 Feb 5.

22.

The adventitia: essential regulator of vascular wall structure and function.

Stenmark KR, Yeager ME, El Kasmi KC, Nozik-Grayck E, Gerasimovskaya EV, Li M, Riddle SR, Frid MG.

Annu Rev Physiol. 2013;75:23-47. doi: 10.1146/annurev-physiol-030212-183802. Epub 2012 Dec 3. Review.

23.

Targeting the adventitial microenvironment in pulmonary hypertension: A potential approach to therapy that considers epigenetic change.

Stenmark KR, Frid MG, Yeager M, Li M, Riddle S, McKinsey T, El Kasmi KC.

Pulm Circ. 2012 Jan-Mar;2(1):3-14. doi: 10.4103/2045-8932.94817.

24.

Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury.

El Kasmi KC, Anderson AL, Devereaux MW, Fillon SA, Harris JK, Lovell MA, Finegold MJ, Sokol RJ.

Hepatology. 2012 May;55(5):1518-28. doi: 10.1002/hep.25500. Epub 2012 Mar 18.

25.

Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension.

Li M, Riddle SR, Frid MG, El Kasmi KC, McKinsey TA, Sokol RJ, Strassheim D, Meyrick B, Yeager ME, Flockton AR, McKeon BA, Lemon DD, Horn TR, Anwar A, Barajas C, Stenmark KR.

J Immunol. 2011 Sep 1;187(5):2711-22. doi: 10.4049/jimmunol.1100479. Epub 2011 Aug 3.

26.

Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis.

Pesce JT, Ramalingam TR, Mentink-Kane MM, Wilson MS, El Kasmi KC, Smith AM, Thompson RW, Cheever AW, Murray PJ, Wynn TA.

PLoS Pathog. 2009 Apr;5(4):e1000371. doi: 10.1371/journal.ppat.1000371. Epub 2009 Apr 10.

27.

LAG-3 regulates plasmacytoid dendritic cell homeostasis.

Workman CJ, Wang Y, El Kasmi KC, Pardoll DM, Murray PJ, Drake CG, Vignali DA.

J Immunol. 2009 Feb 15;182(4):1885-91. doi: 10.4049/jimmunol.0800185.

28.

Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens.

El Kasmi KC, Qualls JE, Pesce JT, Smith AM, Thompson RW, Henao-Tamayo M, Basaraba RJ, König T, Schleicher U, Koo MS, Kaplan G, Fitzgerald KA, Tuomanen EI, Orme IM, Kanneganti TD, Bogdan C, Wynn TA, Murray PJ.

Nat Immunol. 2008 Dec;9(12):1399-406. doi: 10.1038/ni.1671. Epub 2008 Nov 2.

29.

Modulation of adaptive immunity by different adjuvant-antigen combinations in mice lacking Nod2.

Moreira LO, Smith AM, DeFreitas AA, Qualls JE, El Kasmi KC, Murray PJ.

Vaccine. 2008 Oct 29;26(46):5808-13. doi: 10.1016/j.vaccine.2008.08.038. Epub 2008 Sep 27.

30.

ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia.

Faigle M, Seessle J, Zug S, El Kasmi KC, Eltzschig HK.

PLoS One. 2008 Jul 30;3(7):e2801. doi: 10.1371/journal.pone.0002801.

31.

The TLR2-MyD88-NOD2-RIPK2 signalling axis regulates a balanced pro-inflammatory and IL-10-mediated anti-inflammatory cytokine response to Gram-positive cell walls.

Moreira LO, El Kasmi KC, Smith AM, Finkelstein D, Fillon S, Kim YG, Núñez G, Tuomanen E, Murray PJ.

Cell Microbiol. 2008 Oct;10(10):2067-77. doi: 10.1111/j.1462-5822.2008.01189.x. Epub 2008 Jun 28.

32.

The HIF2A gene in familial erythrocytosis.

Eltzschig HK, El Kasmi KC, Eckle T.

N Engl J Med. 2008 May 1;358(18):1965-6; author reply 1966-7. doi: 10.1056/NEJMc080274. No abstract available.

PMID:
18450610
33.

Cutting edge: A transcriptional repressor and corepressor induced by the STAT3-regulated anti-inflammatory signaling pathway.

El Kasmi KC, Smith AM, Williams L, Neale G, Panopoulos AD, Watowich SS, Häcker H, Foxwell BM, Murray PJ.

J Immunol. 2007 Dec 1;179(11):7215-9. Erratum in: J Immunol. 2008 Mar 1;180(5):3612. Panopolous, Athanasia [corrected to Panopoulos, Athanasia D].

34.

General nature of the STAT3-activated anti-inflammatory response.

El Kasmi KC, Holst J, Coffre M, Mielke L, de Pauw A, Lhocine N, Smith AM, Rutschman R, Kaushal D, Shen Y, Suda T, Donnelly RP, Myers MG Jr, Alexander W, Vignali DA, Watowich SS, Ernst M, Hilton DJ, Murray PJ.

J Immunol. 2006 Dec 1;177(11):7880-8.

35.

Platelet-activating factor receptor and innate immunity: uptake of gram-positive bacterial cell wall into host cells and cell-specific pathophysiology.

Fillon S, Soulis K, Rajasekaran S, Benedict-Hamilton H, Radin JN, Orihuela CJ, El Kasmi KC, Murti G, Kaushal D, Gaber MW, Weber JR, Murray PJ, Tuomanen EI.

J Immunol. 2006 Nov 1;177(9):6182-91.

36.

STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils.

Panopoulos AD, Zhang L, Snow JW, Jones DM, Smith AM, El Kasmi KC, Liu F, Goldsmith MA, Link DC, Murray PJ, Watowich SS.

Blood. 2006 Dec 1;108(12):3682-90. Epub 2006 Aug 3.

37.

Cell wall-mediated neuronal damage in early sepsis.

Orihuela CJ, Fillon S, Smith-Sielicki SH, El Kasmi KC, Gao G, Soulis K, Patil A, Murray PJ, Tuomanen EI.

Infect Immun. 2006 Jul;74(7):3783-9.

38.
39.

Differential antigenicity of recombinant polyepitope-antigens based on loop- and helix-forming B and T cell epitopes.

Theisen DM, Bouche FB, El Kasmi KC, von der Ahe I, Ammerlaan W, Demotz S, Muller CP.

J Immunol Methods. 2000 Aug 28;242(1-2):145-57.

PMID:
10986397
40.

Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies.

El Kasmi KC, Fillon S, Theisen DM, Hartter H, Brons NH, Muller CP.

J Gen Virol. 2000 Mar;81(Pt 3):729-35.

PMID:
10675410
41.
42.

A hemagglutinin-derived peptide-vaccine ignored by virus-neutralizing passive antibodies, protects against murine measles encephalitis.

El Kasmi KC, Theisen D, Brons NH, Ammerlaan W, Klingele M, Truong AT, Muller CP.

Vaccine. 1999 May 14;17(19):2436-45.

PMID:
10392626
44.

Enhanced antigenicity of a four-contact-residue epitope of the measles virus hemagglutinin protein by phage display libraries: evidence of a helical structure in the putative active site.

Deroo S, El Kasmi KC, Fournier P, Theisen D, Brons NH, Herrmann M, Desmet J, Muller CP.

Mol Immunol. 1998 Jun;35(8):435-43.

PMID:
9798648

Supplemental Content

Loading ...
Support Center